185 related articles for article (PubMed ID: 16155077)
21. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
22. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
Chen Y; Yu Q; Zhang YW; He FF; Sun ZY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
[TBL] [Abstract][Full Text] [Related]
23. Elevated day 3 follicle-stimulating hormone/luteinizing hormone ratio >or= 2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles.
Liu KE; Greenblatt EM
Fertil Steril; 2008 Aug; 90(2):297-301. PubMed ID: 18023434
[TBL] [Abstract][Full Text] [Related]
24. Predicting poor ovarian response in IVF: use of repeat basal FSH measurement.
Bancsi LF; Broekmans FJ; Looman CW; Habbema JD; te Velde ER
J Reprod Med; 2004 Mar; 49(3):187-94. PubMed ID: 15098888
[TBL] [Abstract][Full Text] [Related]
25. Small doses of LH activity are needed early in ovarian stimulation for better quality oocytes in IVF-ET.
Drakakis P; Loutradis D; Kallianidis K; Liapi A; Milingos S; Makrigiannakis A; Dionyssiou-Asteriou A; Michalas S
Eur J Obstet Gynecol Reprod Biol; 2005 Jul; 121(1):77-80. PubMed ID: 15989987
[TBL] [Abstract][Full Text] [Related]
26. [The predication of ovarian response in control ovarian hyperstimulation by the ratio of basal FSH and LH level].
Liang X; Zhuang G; Zhou C
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):819-21. PubMed ID: 11798975
[TBL] [Abstract][Full Text] [Related]
27. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome.
Thum MY; Bhaskaran S; Bansal AS; Shehata H; Ford B; Sumar N; Abdalla HI
Hum Reprod; 2005 May; 20(5):1272-6. PubMed ID: 15829490
[TBL] [Abstract][Full Text] [Related]
28. Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization.
Roberts JE; Spandorfer S; Fasouliotis SJ; Kashyap S; Rosenwaks Z
Fertil Steril; 2005 Jan; 83(1):37-41. PubMed ID: 15652884
[TBL] [Abstract][Full Text] [Related]
29. Are follicle stimulating hormone measurements predictive of ovarian response to hyperstimulation with human menopausal gonadotrophin?
Oghoetuoma J; Polson DW; Troup SA; Lieberman BA
J Obstet Gynaecol; 1997 Mar; 17(2):188-91. PubMed ID: 15511819
[TBL] [Abstract][Full Text] [Related]
30. Basal follicle--stimulating hormone levels on day 3 of previous cycle are predictive of in vitro fertilization outcome.
Pruksananonda K; Boonkasemsanti W; Virutamasen P
J Med Assoc Thai; 1996 Jun; 79(6):365-9. PubMed ID: 8855610
[TBL] [Abstract][Full Text] [Related]
31. Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase.
de Koning CH; Schoemaker J; Lambalk CB
Fertil Steril; 2004 Sep; 82(3):650-3. PubMed ID: 15374709
[TBL] [Abstract][Full Text] [Related]
32. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
[TBL] [Abstract][Full Text] [Related]
33. Defining poor ovarian response during IVF cycles, in women aged <40 years, and its relationship with treatment outcome.
Kailasam C; Keay SD; Wilson P; Ford WC; Jenkins JM
Hum Reprod; 2004 Jul; 19(7):1544-7. PubMed ID: 15142994
[TBL] [Abstract][Full Text] [Related]
34. Luteal phase estradiol level: a potential predictive marker for successful pregnancy in in vitro fertilization/intracytoplasmic sperm injection.
Ganesh A; Goswami S; Chattopadhyay R; Chakraborty C; Chaudhury K; Chakravarty BN
Fertil Steril; 2009 Apr; 91(4):1018-22. PubMed ID: 18359023
[TBL] [Abstract][Full Text] [Related]
35. The probability of successful IVF outcome after poor ovarian response.
Saldeen P; Källen K; Sundström P
Acta Obstet Gynecol Scand; 2007; 86(4):457-61. PubMed ID: 17486468
[TBL] [Abstract][Full Text] [Related]
36. Intercycle variability of ovarian reserve tests: results of a prospective randomized study.
Kwee J; Schats R; McDonnell J; Lambalk CB; Schoemaker J
Hum Reprod; 2004 Mar; 19(3):590-5. PubMed ID: 14998957
[TBL] [Abstract][Full Text] [Related]
37. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
Jain T; Soules MR; Collins JA
Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
[TBL] [Abstract][Full Text] [Related]
38. "Ovarian age-based" stimulation of young women with diminished ovarian reserve results in excellent pregnancy rates with in vitro fertilization.
Gleicher N; Barad D
Fertil Steril; 2006 Dec; 86(6):1621-5. PubMed ID: 17074322
[TBL] [Abstract][Full Text] [Related]
39. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function.
Barad DH; Weghofer A; Gleicher N
Obstet Gynecol; 2007 Jun; 109(6):1404-10. PubMed ID: 17540814
[TBL] [Abstract][Full Text] [Related]
40. In-vitro fertilisation treatment: factors affecting its results and outcome.
Qublan HS; Malkawi HY; Tahat YA; Areidah S; Nusair B; Khreisat BM; Al-Quraan G; Abu-Assaf A; Hadaddein MF; Abu-Jassar H
J Obstet Gynaecol; 2005 Oct; 25(7):689-93. PubMed ID: 16263545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
